Windtree Therapeutics (WINT)
NASDAQ:WINT
US Market
Holding WINT?
Track your performance easily

Windtree Therapeutics (WINT) Financial Statements

179 Followers

Windtree Therapeutics Financial Overview

Windtree Therapeutics's market cap is currently ―. The company's EPS TTM is $-38.449; its P/E ratio is -0.10; Windtree Therapeutics is scheduled to report earnings on August 15, 2024, and the estimated EPS forecast is $-8.11. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 19.16M$ -4.41M$ -6.59M$ 4.28M$ -11.10M
EBITDA$ 19.28M$ -4.40M-$ 4.42M$ -10.96M
Net Income Common Stockholders$ 10.22M$ -4.42M$ -6.60M$ 4.27M$ -9.67M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.55M$ 7.37M$ 11.47M$ 4.24M$ 6.17M
Total Assets$ 30.10M$ 36.06M$ 40.58M$ 34.95M$ 37.95M
Total Debt$ 1.48M$ 2.16M$ 2.50M$ 1.90M$ 2.28M
Net Debt$ -1.06M$ -5.21M$ -8.97M$ -2.33M$ -3.89M
Total Liabilities$ 14.68M$ 28.57M$ 28.97M$ 28.16M$ 27.94M
Stockholders Equity$ 15.42M$ 7.48M$ 11.60M$ 7.03M$ 10.01M
Cash Flow-
Free Cash Flow$ -2.95M$ -3.87M-$ -2.52M$ -3.38M
Operating Cash Flow$ -2.95M$ -3.85M$ -3.50M$ -2.52M$ -3.38M
Investing Cash Flow-$ -15.00K---
Financing Cash Flow$ 1.03M$ -233.00K$ 10.72M$ 591.00K$ 1.12M
Currency in USD

Windtree Therapeutics Earnings and Revenue History

Windtree Therapeutics Debt to Assets

Windtree Therapeutics Cash Flow

Windtree Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis